Role of nitric oxide in prevention diabetic nephropathy in females after menopause

Arwa Ahmed  Abdel-Raheem; Heba Ibrahim  Hamed; El-Sayed  Fahim; Ayman Saber  Mohamed

doi:10.30574/gscbps.2022.18.1.0034

Authors

Arwa Ahmed Abdel-Raheem Zoology Department - Faculty of Science - Cairo University - Egypt.
Heba Ibrahim Hamed Biochemistry-National Institute of Diabetes and Endocrinology - Cairo University - Egypt.
El-Sayed Fahim Zoology Department - Faculty of Science - Cairo University - Egypt.
Ayman Saber Mohamed Biochemistry-National Institute of Diabetes and Endocrinology - Cairo University - Egypt.

DOI:

https://doi.org/10.30574/gscbps.2022.18.1.0034

Keywords:

Diabetes mellitus, Oxidative stress, Cardiovascular diseases, Diabetic nephropathy, Gender effect

Abstract

Background: Type 2 diabetes mellitus (T2DM) is a complex disease, which affects many organs besides the pancreas such as the liver, brain, eye, stomach, and kidney.

Purpose: The current study aimed to evaluate role of nitric oxide in prevention diabetic nephropathy in females after menopause.

Methods: Our study was carried out on 90 females and 90 males with T2DM aged over 45 years, randomly selected from the outpatient clinic of the National Institute for Diabetes and Endocrinology (NIDE). T2DM patients were divided into 3 subgroups; subgroup 1: patients without any complications, subgroup 2: patients with nephropathy complications (DN), and subgroup 3: patients with cardiovascular compactions (CVD).

Results: Result showed that dyslipidemia and oxidative stress was more pronounced in females rather than in male. While, kidney function markers was worse in male than female.

Conclusion: The current study shows that diabetic females are more susceptible to cardiovascular disease than males due to the depletion of estrogen in postmenopausal women, causing oxidative stress. On the other hand, diabetic males are more susceptible to diabetic nephropathy than females due to a decrease in nitric oxide level, which is considered a kidney protective factor

Metrics

Metrics Loading ...

References

Cirovic A, Vujacic M, Petrovic B, Cirovic A, Zivkovic V, Djonic D, et al. Vascular Complications in Individuals with Type 2 Diabetes Mellitus Additionally Increase the Risk of Femoral Neck Fractures Due to Deteriorated Trabecular Microarchitecture. Clacified Tissue International. 2021.

Saeedi, Petersohn, Salpea P, Malanda. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice. 2019; 157.

Seid MA, Akalu Y, Gela YY, Belsit Y, Diress M, Fekadue SA, et al. Microvascular complications and its predictors among type 2 diabetes mellitus patients at Dessie town hospitals, Ethiopia. Diabetology&Metabolic Syndrom. 2021.

Darenskaya MA, Kolesnikova LI, Kolesnikov SI. Oxidative Stress: Pathogenetic Role in Diabetes Mellitus and Its Complications and Therapeutic Approaches to Correction. Bulletin of Experimental Biology and Medicin. 2021; 179-189.

Kosiborod M, Gomes MB, Nicolucci A. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovascular Diabetology. 2018; 17(1).

Cheema S, Malsonneuve P, Zirie M. Risk Factors for Microvascular Complications of Diabetes in a High-Risk Middle East Population. National Center for Biotechnology Information. 2018; 1-8.

Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M. Complications of Diabetes 2017. Jorna of Diabetes research. 2018.

Pickering PJ, Rosado CJ, Sharma A, Buksh S, Tate M, de Haan JB. Recent novel approaches to limit oxidative stress and inflammation in diabetic complications. Clinical & Translational Immunology. 2018; 7(4): e1016.

Chandirasegaran G, Elanchezhiyan C, Ghosh K, Manivel G, Hassan T. Diabetes Mellitus Induced Oxidative Stress, Inflammation and Apoptosis: A Concise Review. EC Diabetes and Metabolic Research. 2019; 3(1): 10-17.

Nazar CM. Diabetic nephropathy; principles of diagnosis and treatment of diabetic kidney disease. J Nephropharmacol. 2014; 3(1): 15-20.

Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress—A concise review. Saudi Pham J. 2016; 24(5): 547–553.

Ebaid H, Bashandy SAE, Abdel-Mageed AM, Al-Tamimi J, Hassan I, Alhazza IM. Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress. Nutrition & Metabolism. 2020; 17: 6.

Sifuentes-Franco S, Padilla-Tejeda D, Carrillo-Ibarra S, Miranda-Díaz AG. Oxidative stress, apoptosis, and mitochondrial function in diabetic nephropathy. Int. J. Endocrinol. 2018; 1875870.

Abdul-Ghani M, DeFronzo RA, Del Prato S, Chilton R, Singh R, Ryder REJ. Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? Diabetes Care. 2017; 40(7): 813-820.

Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013; 93: 137-188.

Cambiaso CL, Collet-Cassart D, Lievens M. Immunoassay of low concentrations of albumin in urine by latex particle counting. Clin Chem. 1988; 34: 416-418.

Schirmeister J. Determination of creatinine in serum. Dtsch Med Wschr. 1964; 89: 1940.

Freund A, Johnson SB, Rosenbloom A, Alexander B, Hansen CA. Subjective symptoms, blood glucose estimation, and blood glucose concentrations in adolescents with diabetes. Diabetes Care. 1986; 9: 236–243.

Gallop PM, Flückige R, Hanneken A, Mininsohn MM, Gabbay KH. Chemical quantitation of hemoglobin glycosylation: Fluorometric detection of formaldehyde released upon periodate oxidation of glycoglobin. Analytical Biochemistry. 1981; 117(2): 427-432.

Kornberg A, Horecker BL. Glucose- 6- Phosphate Dehydrogenase. Methods Enzymol. 1955; 1: 323-329.

Poso AR, Lampinen KJ, Rasanen LA. Distribution of lactate between red blood cells and plasma after exercise. Equine vet. J., Suppl. 1995; 18: 231-234.

Marsch W. Determination of arginase activity. Clin. Chem. 1965; 11: 620-630.

Basu M, Saha S, Ukil A. pectrophotometric Assessment of Heme Oxygenase-1 Activity in Leishmania-infected Macrophages. Bio-protocol. 2020; 10(7): e3578.

Franco RS. Hemoglobin. In Kaplan A, editor. Clin Chem. The C.V. Mosby Co. St Louis: Princeton; 1984. 1294-1296& 418.

Walter M, Gerade H. Ultramicromethod for determination of conjugated and total bilirubin in serum or plasma. Microchem. J. 1970; 15: 231-238.

Stein EA, Myers G. Lipids, lipoproteins and apolipoproteins.In: Burtis, C.A., Ashwood, E.R. (Eds.). In In Tietz Textbook of Clinical Chemistry.: WB Saunders Company; 1994. 1002–993.

Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia s and its application to the enzymatic assay of total cholesterol in serum. Clin. Chem. 1973; 19(12): 1350–1356.

Wieland H, Seidel D. A simple specific method for precipitation of low density lipoproteins. J. Lipid Res. 1983; 24(7): 904-909.

Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin. Chem. 1977; 23: 882-884.

Fawcett JK, Soctt JE. A RAPID AND PRECISE METHOD FOR THE DETERMINATION OF UREA. J Clin Pathol. 1960; 13: 156-159.

Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal.Biochem. 1979; 95: 351-358.

Beutler E, Duron O, Kelly MB. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 1963; 61: 882–888.

Aebi H. Catalase in vitro. Methods enzymol. 1984; 105: 121-126.

Montgomery HAC, Dymock JF. The determination of nitrite in water. Analyst. 1961; 86: 414–416.

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF. A new equation to estimate glomerular filtration rate. 3rd ed. Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, editors.: Ann Intern Med. 2009.

Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138: 271-281.

ADA. American Diabetes Association; Classification and diagnosis of diabetes: standards of medical care in diabetes. Diabetes Care. 2019; 42(5): 13–28.

Willer K, Kosi L, Lin L, Mihaljevic R. Gender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trials A. Diabetes, Obesity and Metabolism. 2015; 17: 533–540.

Rajab AM, Haider KH. Hyperglycemia and RBCs: too sweet to survive. International Journal of Diabetes in Developing Countries. 2018; 38: 357-365.

Al-Adhar SI, Karem KK, Jassim WK. An Evaluation Of Hemoglobin Concentration in Patients With Diabetes Mellitus Type 2. International Journal of Drug Delivary Technology. 2019; 9(2): 177-181.

Wiliam MG. The sex difference in haemoglobin levels in adults - mechanisms, causes, and consequences. ELSEVIER. 2014; 28(2): 41-7.

Kahn SE, Hull RL. Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006; 444(7121): 840-846.

Sharma P, Nagy CD, Blumenthal RS. Dyslipidemia Management in Women and Men:Exploring Potential Gender Differences. In Legato M, editor. Principles of Gender-Specific Medicin (Second Edition).: Science direct. 2010. 175-185.

Peter NVB, Robert T. Hypertension in Diabetic Nephropathy: Epidemiology, Mechanisms, and Management. Adv Chronic Kidney Dis. 2011; 18(1): 28–41.

Carette C, Dubois-Lafogue D, Gautier JF, Timsit J. Diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency: From one crisis to another. Diabetes&Metabolism. 2011; 37(1): 79-82.

Reckelhoff F. Gender Differences in the Regulation of Blood Pressure. Hypertension. 2001; 37: 1199–1208.

Silbiger S, Neugarten J. Gender and Human Chronic Renal Disease. Gender Medicine. 2008; 5: S3-S10.

Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. American journal of physiology.Renal physiology. 2016; 311(6).

Carlström M. Nitric oxide signalling in kidney regulation and cardiometabolic health. Nat Rev Nephrol. 2021; 17: 575–590.

Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol. 2008; 294: F1–F9.

Erdely A, Greenfeld Z, Wagner L, Baylis C. Sexual dimorphism in the aging kidney: Effects on injury and nitric oxide system. Kidney Int. 2003; 63: 1021–1026.

Ahmed SB, Fisher NDL, Hollenberg NK. Gender and the Renal Nitric Oxide Synthase System in Healthy Humans. Clin J Am Soc Nephrol. 2007; 7: 916-931.

Cervellati , Bergamini. Oxidative damage and the pathogenesis of menopause related disturbances and diseases. Clinical Chemistry and Laboratory Medicine (CCLM). 2015.